Generic Drugs: 'Competitive' Exclusivity Benefited Few Sponsors But Is Increasingly Popular - McDermott Will & Emery

Generic Drugs: ‘Competitive’ Exclusivity Benefited Few Sponsors But Is Increasingly Popular